Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hydrochloride, Levalbuterol
2. Hydrochloride, Levosalbutamol
3. Levalbuterol
4. Levosalbutamol Hydrochloride
5. Xopenex
1. 50293-90-8
2. Levalbuterol Hcl
3. Xopenex
4. (r)-albuterol Hydrochloride
5. Levosalbutamol Hydrochloride
6. R-albuterol Hydrochloride
7. (r)-salbutamol Hydrochloride
8. Levalbuterol Hydrochloride [usan:usp]
9. Nsc-759255
10. Albuterol Hydrochloride, R-
11. Wdq1526qjm
12. (r)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol Hydrochloride
13. (r)-albuterol
14. 50293-90-8(hcl)
15. 148563-16-0
16. Alfa1-[[1,1-dimethylethylamino]methyl]-4-hydroxy-1-(s),3-benzene Dimethanol Hydrochlorid
17. (-)-salbutamol Hydrochloride
18. Zopenex
19. Levalbuterol Hydrochloride [usan]
20. Unii-wdq1526qjm
21. (r)-4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol Hydrochloride
22. Xopenex (tn)
23. Zopenex [common Misspelling Of Xopenex]
24. Salbutamol (hydrochloride)
25. Schembl40682
26. Chembl1201061
27. Albuterol (r)-form Hydrochloride
28. Levalbuterol Hydrochloride (usp)
29. Dtxsid20198296
30. Pharmakon1600-01505811
31. Bcp04477
32. Ccg-39986
33. Mfcd08067728
34. Nsc759255
35. Akos015961919
36. (r)-salbutamol ((r)-albuterol Hcl)
37. Bs-1006
38. Nsc 759255
39. (r)-alpha(sup 1)-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol Hydrochloride
40. 4-[(1r)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol Hydrochloride
41. 1,3-benzenedimethanol, Alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, Hydrochloride, (alpha1r)-
42. 2-(hydroxymethyl)-4-{(1r)-1-hydroxy-2-[(2-methyl-2-propanyl)amino ]ethyl}phenol Hydrochloride (1:1)
43. Ac-23919
44. Levalbuterol Hydrochloride [usp-rs]
45. Levalbuterol Hydrochloride, >=98% (hplc)
46. Levosalbutamol Hydrochloride [mart.]
47. Levosalbutamol Hydrochloride [who-dd]
48. Albuterol (r)-form Hydrochloride [mi]
49. D02281
50. Levalbuterol Hydrochloride [orange Book]
51. 293l908
52. A928075
53. Levalbuterol Hydrochloride [usp Monograph]
54. Q27292577
55. 4-[(1r)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;hydrochloride
56. Alfa1-[[1,1-dimethylethylamino]methyl]-4-hydroxy-1-(s),3-benzenedimethanolhydrochlorid
57. Levalbuterol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
58. (r)-.alpha.(sup 1)-((tert-butylamino)methyl)-4-hydroxy-m-xylene-.alpha.,.alpha.'-diol Hydrochloride
Molecular Weight | 275.77 g/mol |
---|---|
Molecular Formula | C13H22ClNO3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 275.1288213 g/mol |
Monoisotopic Mass | 275.1288213 g/mol |
Topological Polar Surface Area | 72.7 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 227 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levalbuterol hydrochloride |
Drug Label | Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selectiv... |
Active Ingredient | Levalbuterol hydrochloride |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.021% base; eq 0.25% base; eq 0.0103% base; eq 0.042% base |
Market Status | Prescription |
Company | Teva Parenteral; Teva Pharms Usa; Mylan Speclt; Cipla; Watson Labs |
2 of 2 | |
---|---|
Drug Name | Levalbuterol hydrochloride |
Drug Label | Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selectiv... |
Active Ingredient | Levalbuterol hydrochloride |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.021% base; eq 0.25% base; eq 0.0103% base; eq 0.042% base |
Market Status | Prescription |
Company | Teva Parenteral; Teva Pharms Usa; Mylan Speclt; Cipla; Watson Labs |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?